May 21, 2020 / 8:52 PM / 9 days ago

BRIEF-Cellect Biotechnology Reports Q1 Loss Per Share Of $0.002

May 21 (Reuters) - Cellect Biotechnology Ltd:

* CELLECT BIOTECHNOLOGY REPORTS FIRST QUARTER 2020 FINANCIAL AND OPERATING RESULTS; CONTINUES TO DEMONSTRATE SIGNIFICANT PROGRESS DESPITE ADJUSTED OPERATIONS DUE TO COVID-19

* Q1 LOSS PER SHARE $0.002 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below